Due to a decreasing trend shown by the exposure to EPAG in patients with kidney impairment, a close monitoring of kidney function, such as measuring serum creatinine and/or urine analysis, is required for patients with kidney impairment ( 11 ).
← all excerpts
Avatrombopag as alternative therapy for severe aplastic anemia patients who are intolerant or unresponsive to eltrombopag.
1
—
—